Lucy Scientific Discovery Receives Nasdaq Notification Of Non-Compliance

5/28/24 4:08:34 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $LSDI alert in real time by email

Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule").

Get the next $LSDI alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LSDI

Date	Price Target	Rating	Analyst

More analyst ratings

Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule"). On May 21, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") that, per Nasdaq Listing Rule 5250(c)(1) (the "Filings Rule"), the Company is delinquent in filing its Quarterly Report on Form 1
5/28/24 4:05:00 PM ET
$LSDI
Biotechnology: Pharmaceutical Preparations
Health Care
Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide announces that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The reverse share split will become effective on Monday, February 26, 2024 (the "Effective Date"), and the shares are expected to begin trading on the split-adjusted b
2/16/24 4:05:00 PM ET
$LSDI
Biotechnology: Pharmaceutical Preparations
Health Care
Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ:LSDI) is a pioneer in alternative mental health treatments and looking to grab its share of the leadership mantle, as it uncovers alternative mental health treatments. From herbal remedies to psychedelics, like psilocybin and MDMA, Lucy Scientific is working to provide the ingredients for groundbreaking mental health therapies and are well positioned to support this space as it continues to grow. Mental Health Refocus Mental health issues and treatments are nearly as old as mankind, but, as mental health disorders reach epidemic proportions, affecting millions of Americans every year, it seems that the tre
10/18/23 7:00:00 AM ET
$LSDI
Biotechnology: Pharmaceutical Preparations
Health Care

Lucy Scientific Discovery Receives Nasdaq Notification Of Non-Compliance
Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule").
5/28/24 4:08:34 PM ET
$LSDI
Biotechnology: Pharmaceutical Preparations
Health Care
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Sharps Technology (NASDAQ:STSS) shares rose 50.5% to $0.32 during Friday's after-market session. The market value of their outstanding shares is at $5.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares increased by 9.75% to $2.25. The market value of their outstanding shares is at $3.2 million. Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 6.89% to $0.93. The market value of their outstanding shares is at $1.6 million. Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by 6.4% to $1.33. The company's market cap stands at $5.6 million. Aclaris Therapeutics (NASDAQ:ACRS) shares rose 5.4% to $1.17. The market value of their outstanding shares is at $83.3 mi
5/24/24 4:31:11 PM ET
$ACRS
$ADIL
$BCLI
$CYCC
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers GT Biopharma (NASDAQ:GTBP) shares rose 173.5% to $8.53 during Monday's regular session. The market value of their outstanding shares is at $11.7 million. As per the press release, Q1 earnings came out 3 days ago. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 78.07% to $0.21. The company's market cap stands at $7.9 million. NKGen Biotech (NASDAQ:NKGN) stock moved upwards by 48.66% to $1.67. The market value of their outstanding shares is at $37.4 million. Scorpius Holdings (AMEX:SCPX) shares rose 36.98% to $0.14. The market value of their outstanding shares is at $5.1 million. Scilex Holding (NASDAQ:SCLX) stock moved upwards by 32.22% to $1.19. The market value of their outstand
5/20/24 12:31:16 PM ET
$AIH
$AKAN
$DMTK
$GTBP
Medical Specialities
Health Care
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations

Lucy Scientific Discovery Receives Nasdaq Notification Of Non-Compliance

Chat with this insight

Recent Analyst Ratings for
$LSDI

$LSDI
SEC Filings

Lucy Scientific Discovery Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Lucy Scientific Discovery Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

SEC Form NT 10-Q filed by Lucy Scientific Discovery Inc.

$LSDI
Leadership Updates

Live Leadership Updates

Lucy Scientific Discovery Inc. Taps Fortune 500 Veteran and Current Executive Chairman Richard Nanula as New CEO

Lucy Scientific Discovery Appoints Former B.C. Solicitor General Kash Heed as a Special Advisor

$LSDI
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4: Mcelvany Christopher acquired $284,167 worth of shares (118,403 units at $2.40) and converted options into 366,187 shares

SEC Form 4: Kazeminy Assad J acquired $204,000 worth of shares (85,000 units at $2.40)

SEC Form 4: Susin Livio acquired $22,342 worth of shares (9,309 units at $2.40), increasing direct ownership by 7% to 134,809 units

$LSDI
Press Releases

Fastest customizable press release news feed in the world

$LSDI
Financials

Live finance-specific insights

$LSDI
Market Insights

Live Market Insights

Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health

Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition

Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction